Podcast
In this episode, we speak with microbiologists Theresa Enkirch and Maximilian Riess who explain how wastewater surveillance works and why it is becoming increasingly valuable for public health.
12840 results
News
European Immunization Week (EIW) is an initiative led by the World Health Organization (WHO) to raise awareness about the vital role immunisation plays to prevent diseases and protect life. This year’s EIW runs from 19-25 April.
Overview of annual planned procurement procedures at ECDC.
News story
The call for abstracts for the ESCAIDE 2026 is open until 18 May.
Since the previous update on 2 March 2026, and as of 30 March 2026, no new MERS cases have been reported by WHO or national health authorities.
A worldwide epidemiological summary of the countries most affected by cholera.
Map
Since 25 February 2026 and as of 30 March 2026, 17 723 new cholera cases, including 212 new deaths, have been reported worldwide.
Map
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Map
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Map
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Graph
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Operational support
This reporting protocol is for the 2026 data call for antimicrobial resistance (AMR) surveillance data, collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2025.
European Antimicrobial Resistance Surveillance Network (EARS-Net) surveillance data for 2025
English (1.93 MB - PDF)
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
Assessment
ECDC cooperates with countries under the EU enlargement policy to improve their infectious disease prevention and control systems and public health workforce and prepare them for their future participation in ECDC’s work.
ECDC review of communicable disease surveillance in Ukraine
English (324.85 KB - PDF)
Tools for public health
Epi+ is a multi-hazard, open-source, event-based surveillance platform for EU/EEA countries that enables public health authorities to monitor, manage and respond to health events at the national level.
This page includes the selection committees that have been appointed for the ongoing selection procedures.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 April 2026, and includes updates on avian influenza, dengue, and an overview of respiratory virus epidemiology in the EU/EEA.
Communicable disease threats report, 4-10 April 2026, Week 15
English (2.07 MB - PDF)
Infographic
Most respiratory virus activity remains low overall across the EU/EEA. Influenza and COVID 19 circulation are low or continuing to decline. RSV activity remains elevated, with early indications of a gradual decline.
Update
ECDC, in partnership with the Africa Centres for Disease Control and Prevention (Africa CDC) and the Health Information Systems Program South Africa (HISP SA), are piloting a mobile application for event-based surveillance to enable the rapid collection and assessment of information about events that may signal a public health threat.
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 March-3 April 2026 and includes updates on SARS-CoV-2 variant classification, Middle East respiratory syndrome coronavirus (MERS-CoV), cholera, HIV, and avian influenza.
Communicable disease threats report, 28 March – 3 April 2026, Week 14
English (5.14 MB - PDF)
Risk assessment
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Risk assessment: Monkeypox multi-country outbreak
English (598.63 KB - PDF)
Public health guidance
Since 16 May 2022, and as of 4 April 2023, 21 170 cases of mpox (formerly known as monkeypox) have been reported by countries within the European Union/European Economic Area (EU/EEA).
Public health considerations for mpox in EUEEA countries 2023
English (3.93 MB - PDF)
Risk assessment
Since early May, and as of 11 October 2022, 20 455 confirmed cases of monkeypox (MPX) have been reported from 29 European Union/European Economic Area (EU/EEA) countries, including four deaths. As of 30 September, MPX confirmed cases reported from EU/EEA countries represented almost one third (29.7%) of the cases reported to the World Health Organization (WHO) globally (68 267 cases).
Monkeypox multi-country outbreak - second update
English (540.92 KB - PDF)